Andrew J. Schwab

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Andrew J. Schwab
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew J. Schwab:

Company Role Class Num Shares Value Price $ Report Date Ownership
Skye Bioscience, Inc. Director, 10%+ Owner Common Stock 8,167,206 $28,258,532 $3.46 21 Aug 2025 By 5AM Ventures VII, L.P.
Enliven Therapeutics, Inc. Director, 10%+ Owner Common Stock 960,383 $14,535,397 $15.14 23 Feb 2023 Indirect
Camp4 Therapeutics Corp Director, 10%+ Owner Common Stock 2,625,145 $5,302,792 $2.02 11 Sep 2025 By 5AM Ventures VI, L.P.
Skye Bioscience, Inc. Director, 10%+ Owner Common Stock 1,457,064 $4,983,158 $3.42 22 Aug 2025 By 5AM Ventures II, L.P.
Camp4 Therapeutics Corp Director, 10%+ Owner Common Stock 2,941,176 $4,499,999 $1.53 11 Sep 2025 By 5AM Ventures VII, L.P.
Camp4 Therapeutics Corp Director, 10%+ Owner Common Stock 302,770 $611,595 $2.02 11 Sep 2025 By 5AM Opportunities II, L.P.
Skye Bioscience, Inc. Director, 10%+ Owner Common Stock 57,493 $196,626 $3.42 22 Aug 2025 By 5AM Co-Investors II, L.P.
Skye Bioscience, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 35,000 $1,190 $0.0170 24 Feb 2025 Direct
Pear Therapeutics, Inc. Director, 10%+ Owner Class A Common Stock 14,648,641 03 Dec 2021 by 5AM Ventures IV, L.P.
Pear Therapeutics, Inc. Director, 10%+ Owner Class A Common Stock 3,372,769 03 Dec 2021 by 5AM Opportunities I, L.P.
Pear Therapeutics, Inc. Director, 10%+ Owner Class A Common Stock 610,361 03 Dec 2021 by 5AM Co-Investors IV, L.P.
Enliven Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 27,567 23 Feb 2023 Direct
Camp4 Therapeutics Corp Director, 10%+ Owner Stock Option (Right to Buy) 9,000 25 Jun 2025 Direct
Camp4 Therapeutics Corp Director, 10%+ Owner Series A Prime Preferred Stock 0 15 Oct 2024 Indirect
Camp4 Therapeutics Corp Director, 10%+ Owner Series B Preferred Stock 0 15 Oct 2024 Indirect

Insider Reports Filed by Andrew J. Schwab

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CAMP Camp4 Therapeutics Corp 11 Sep 2025 1 +$4,499,999 4 Director, 10%+ Owner 15 Sep 2025, 20:14
SKYE Skye Bioscience, Inc. 21 Aug 2025 4 -$800,548 4 Director, 10%+ Owner 22 Aug 2025, 19:07
CAMP Camp4 Therapeutics Corp 25 Jun 2025 1 $0 4 Director, 10%+ Owner 27 Jun 2025, 16:02
SKYE Skye Bioscience, Inc. 24 Feb 2025 1 $0 4 Director 26 Feb 2025, 19:45
SKYE Skye Bioscience, Inc. 28 Oct 2024 1 $0 4 Director 30 Oct 2024, 20:30
CAMP Camp4 Therapeutics Corp 15 Oct 2024 7 +$9,999,990 4 Director, 10%+ Owner 15 Oct 2024, 17:48
CAMP Camp4 Therapeutics Corp 10 Oct 2024 0 $0 3 Director, 10%+ Owner 10 Oct 2024, 21:05
SKYE Skye Bioscience, Inc. 11 Sep 2024 6 -$1,750,352 4 Director, 10%+ Owner 13 Sep 2024, 18:56
SKYE Skye Bioscience, Inc. 13 Mar 2024 1 +$4,500,000 4 Director, 10%+ Owner 15 Mar 2024, 16:15
SKYE Skye Bioscience, Inc. 29 Feb 2024 1 $0 4 Director 04 Mar 2024, 16:04
SKYE Skye Bioscience, Inc. 31 Jan 2024 1 +$12,026,031 4 Director, 10%+ Owner 02 Feb 2024, 16:35
SKYE Skye Bioscience, Inc. 06 Nov 2023 1 $0 4 Director 06 Nov 2023, 20:29
SKYE Skye Bioscience, Inc. 25 Aug 2023 1 $0 4 Director 29 Aug 2023, 22:36
SKYE Skye Bioscience, Inc. 18 Aug 2023 6 +$8,782,771 4 Director, 10%+ Owner 22 Aug 2023, 18:21
SKYE Skye Bioscience, Inc. 18 Aug 2023 0 $0 3 Director, 10%+ Owner 22 Aug 2023, 18:19
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 1 $0 4 Director, 10%+ Owner 06 Apr 2023, 20:22
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 2 $0 4 Director 27 Feb 2023, 20:55
ELVN Enliven Therapeutics, Inc. 23 Feb 2023 0 $0 3 Director 27 Feb 2023, 20:49
/report/000106299321012396-schwab-andrew-j-2021-12-03 Pear Therapeutics, Inc. 03 Dec 2021 4 +$2,000,000 4 Director, 10%+ Owner 07 Dec 2021, 16:25
/report/000106299321012363-schwab-andrew-j-2021-12-03 Pear Therapeutics, Inc. 03 Dec 2021 0 $0 3 Director, 10%+ Owner 07 Dec 2021, 16:08